Wikidata

(Q52874022)

English

PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer.

scientific article published on 8 September 2014

In more languages
default values for all languages
No label defined

No description defined

Statements

title
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25199759
retrieved
9 May 2018
reference URL
http://europepmc.org/abstract/MED/25199759
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q52874022&oldid=1256783241"